Ethan Huff (NaturalNews.com), 2024-09-05: NaturalNews article by Ethan Huff reporting the 2017 Mexican cancer-stem-cell study as evidence that ivermectin beats chemotherapy in breast cancer, and quoting a tweet by Dr. William Makis recommending ivermectin for every advanced breast cancer patient.
All in all, ivermectin was found to work significantly better – up to 100-fold and with no serious side effects – than chemotherapy drugs.
Ethan Huff (NaturalNews.com), 2024-09-05: NaturalNews article by Ethan Huff reporting the 2017 Mexican cancer-stem-cell study as evidence that ivermectin beats chemotherapy in breast cancer, and quoting a tweet by Dr. William Makis recommending ivermectin for every advanced breast cancer patient. Recorded as published and attributed to NaturalNews/Ethan Huff, without judging the outlet. The article's headline claim rests on two things: (1) the Dominguez-Gomez 2018 Mol Med Rep cell study (IVA-11), which found ivermectin preferentially killed CSC-enriched MDA-MB-231 populations while paclitaxel did the opposite – a cell-culture viability comparison, not a clinical comparison; and (2) the '>100-fold' figure, which the article takes from the 2009 MIT/Harvard salinomycin screen (Gupta et al., Cell 2009, IVA-18) where the 100-fold figure refers to SALINOMYCIN, not ivermectin. The article calls the Mexican study 'the more recent study from 2017' (it appeared online 8 Dec 2017, in print Feb 2018). No patients, no doses, no survival data are reported in the article. It also states 'ivermectin was found to work significantly better … than chemotherapy drugs', which the cited paper does not show: the paper compared viability of cell subpopulations in vitro. Study type: news.
